Immutep Limited

Immutep Limitedverified

IMMP

Price:

$1.98

Market Cap:

$487.62M

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-004 and INSIGHT-003, which is in a Phase ...[Read more]

Industry

Biotechnology

IPO Date

2012-04-19

Stock Exchange

NASDAQ

Ticker

IMMP

The ROE as of December 2024 (TTM) for Immutep Limited (IMMP) is -14.12%

According to Immutep Limited’s latest financial reports and current stock price. The company's current ROE is -14.12%. This represents a change of 37.73% compared to the average of -10.25% of the last 4 quarters.

Immutep Limited (IMMP) Historical ROE (quarterly & annually)

How has IMMP ROE performed in the past?

The mean historical ROE of Immutep Limited over the last ten years is -64.97%. The current -14.12% ROE has changed -78.26% with respect to the historical average. Over the past ten years (40 quarters), IMMP's ROE was at its highest in in the June 2012 quarter at 0%. The ROE was at its lowest in in the December 2015 quarter at -138.26%.

Quarterly (TTM)
Annual

Average

-64.97%

Median

-40.63%

Minimum

-175.59%

Maximum

-29.23%

Immutep Limited (IMMP) ROE by Quarter and Year

Discovering the peaks and valleys of Immutep Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 120.49%

Maximum Annual ROE = -29.23%

Minimum Annual Increase = -79.89%

Minimum Annual ROE = -175.59%

Quarterly (TTM)
Annual
YearROEChange
2023-29.23%-14.62%
2022-34.24%-16.10%
2021-40.81%0.90%
2020-40.45%-39.38%
2019-66.72%75.46%
2018-38.02%7.70%
2017-35.30%-79.89%
2016-175.59%34.84%
2015-130.22%120.49%
2014-59.06%13.46%

Immutep Limited (IMMP) Average ROE

How has IMMP ROE performed in the past?

The current ROE of Immutep Limited (IMMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-34.76%

5-year avg

-42.29%

10-year avg

-64.97%

Immutep Limited (IMMP) ROE vs. Peers

How is IMMP’s ROE compared to its peers?

Immutep Limited’s ROE is greater than CohBar, Inc. (-58.44%), less than Ocean Biomedical, Inc. (75.64%), greater than Elevation Oncology, Inc. (-59.73%), less than AVROBIO, Inc. (29.68%), greater than Zura Bio Limited (-39.61%), less than CNS Pharmaceuticals, Inc. (0%), less than ZyVersa Therapeutics, Inc. (695.91%), greater than eFFECTOR Therapeutics, Inc. (-25512.50%), less than VectivBio Holding AG (2.18%), greater than Enveric Biosciences, Inc. (-56.92%), greater than null (-201.01%),

Build a custom stock screener for Immutep Limited (IMMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (IMMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Immutep Limited's ROE?

How is the ROE calculated for Immutep Limited (IMMP)?

What is the highest ROE for Immutep Limited (IMMP)?

What is the 3-year average ROE for Immutep Limited (IMMP)?

What is the 5-year average ROE for Immutep Limited (IMMP)?

How does the current ROE for Immutep Limited (IMMP) compare to its historical average?